Quarterly report pursuant to Section 13 or 15(d)

Summary Financial Information by Reportable Segment (Details)

v3.20.2
Summary Financial Information by Reportable Segment (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Segment Reporting        
Sales $ 380,319 $ 423,801 $ 1,101,442 $ 1,214,697
Equity in net income 183 17,261 20,025 31,625
Refining Services        
Segment Reporting        
Sales 106,840 117,522 296,258 338,874
Catalysts        
Segment Reporting        
Sales 23,020 25,565 73,043 62,226
Performance Materials        
Segment Reporting        
Sales 104,517 115,116 274,180 294,925
Performance Chemicals        
Segment Reporting        
Sales 145,942 165,598 457,961 518,672
Operating segments        
Segment Reporting        
Sales 383,762 427,030 1,111,649 1,225,138
Segment Adjusted EBITDA 115,287 145,377 350,743 399,240
Operating segments | Refining Services        
Segment Reporting        
Sales 107,604 118,335 298,727 341,469
Segment Adjusted EBITDA 44,272 51,166 116,451 133,721
Operating segments | Catalysts        
Segment Reporting        
Sales 23,071 25,612 73,143 62,335
Segment Adjusted EBITDA 11,762 31,638 59,741 79,372
Operating segments | Performance Materials        
Segment Reporting        
Sales 104,574 115,134 274,346 295,095
Segment Adjusted EBITDA 25,334 25,769 66,148 65,505
Operating segments | Performance Chemicals        
Segment Reporting        
Sales 148,513 167,949 465,433 526,239
Segment Adjusted EBITDA 33,919 36,804 108,403 120,642
Eliminations        
Segment Reporting        
Sales (3,443) (3,229) (10,207) (10,441)
Zeolyst Joint Venture | Catalysts        
Segment Reporting        
Sales 26,552 54,414 99,695 123,106
Segment Adjusted EBITDA 5,331 22,628 35,911 48,621
Equity in net income 76 17,248 19,882 31,548
Amortization of investment in affiliate step-up 1,658 1,658 4,975 5,875
Joint venture depreciation, amortization and interest $ 3,597 $ 3,722 $ 11,054 $ 11,198